Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Todd Fralich"'
Autor:
Samir K Gupta, Albert M Anderson, Ramin Ebrahimi, Todd Fralich, Hiba Graham, Valeska Scharen-Guivel, John F Flaherty, Claude Fortin, Robert C Kalayjian, Anita Rachlis, Christina M Wyatt
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e92717 (2014)
The predictors of Fanconi syndrome (FS) accompanied by renal function decline with use of the antiretroviral tenofovir disoproxil fumarate (TDF) have not been assessed. In addition, the natural history of renal recovery from FS after TDF discontinuat
Externí odkaz:
https://doaj.org/article/29ad62a9d52a4859ba6d9bf7fd0123b2
Autor:
Jan van Lunzen, Ramin Ebrahimi, Frank J. Palella, Peter Ruane, Elizabeth Elbert, David Shamblaw, Jason Flamm, Danielle Porter, Jason Hindman, Todd Fralich, Pablo Tebas, Martin Fisher, Shampa De-Oertel, Brian Gazzard, Kirsten L. White
Publikováno v:
AIDS. 28:335-344
OBJECTIVE To evaluate the efficacy and safety of antiretroviral simplification from a ritonavir-boosted protease inhibitor-based regimen [protease inhibitor+RTV+two nucleos(t)ide reverse transcriptase inhibitors (NRTIs); ≥6 months of exposure prior
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 65(3)
The Single-Tablet Regimen (STaR) study (GS-US-264-0110) is a 96-week phase 3b study evaluating the safety and efficacy of 2 single-tablet regimens, rilpivirine/emtricitabine/tenofovir DF (RPV/FTC/TDF), and efavirenz/emtricitabine/tenofovir DF (EFV/FT
Autor:
Danielle Porter, Susan K. Chuck, Jan van Lunzen, Keith Henry, C Cohen, Mark Bloch, William Towner, Shampa De-Oertel, Ivan Walker, Kirsten L. White, Edmund Wilkins, Ramin Ebrahimi, David A. Wohl, Todd Fralich, Jose R. Arribas
Publikováno v:
AIDS (London, England). 28(7)
Objectives To compare the safety and efficacy of the two single-tablet regimens (STRs), rilpivirine/emtricitabine/tenofovir disoproxil fumarate (RPV/FTC/TDF) and efavirenz/emtricitabine/tenofovir DF (EFV/FTC/TDF), in HIV-1-infected, treatment-naive a
Autor:
Hiba Graham, Albert M. Anderson, Anita Rachlis, Todd Fralich, Samir K. Gupta, Claude Fortin, Valeska Scharen-Guivel, Ramin Ebrahimi, Christina M. Wyatt, Robert C. Kalayjian, John F. Flaherty
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e92717 (2014)
PLoS ONE
PLoS ONE
Objective The predictors of Fanconi syndrome (FS) accompanied by renal function decline with use of the antiretroviral tenofovir disoproxil fumarate (TDF) have not been assessed. In addition, the natural history of renal recovery from FS after TDF di
Autor:
Danielle Porter, Mark Bloch, Ramin Ebrahimi, Keith Henry, Shampa De-Oertel, C Cohen, Todd Fralich, Jose R. Arribas, David A. Wohl, William J. Towner, Romina Quercia
Publikováno v:
Journal of the International AIDS Society. 16
Autor:
Jason Flamm, Brian Gazzard, J van Lunzen, Kirsten L. White, Romina Quercia, Martin Fisher, David Shamblaw, Danielle Porter, Pablo Tebas, Peter Ruane, Todd Fralich, Shampa De-Oertel, F Pallela, Ramin Ebrahimi
Publikováno v:
Journal of the International AIDS Society. 16
Autor:
David A. Wohl, William J. Towner, Mark Bloch, J van Lunzen, Edmund Wilkins, B. Guyer, Kirsten L. White, K Henry, D Poulin Porter, Jose R. Arribas, C Cohen, Hai-Lin Wang, Todd Fralich
Publikováno v:
Journal of the International AIDS Society. 15
Simplified antiretroviral treatment (ART) regimens improve quality of life and long-term medication adherence. Emtricitabine/rilpivirine/tenofovir DF (FTC/RPV/TDF) is a well-tolerated, once daily single tablet regimen (STR) treatment option. This is
Autor:
Frank J. Palella, Pablo Tebas, J van Lunzen, Danielle Porter, Jason Flamm, Martin Fisher, Todd Fralich, Kirsten L. White, Brian Gazzard, W Guyer, Ramin Ebrahimi, David Shamblaw, Peter Ruane
Publikováno v:
Journal of the International AIDS Society. 15
Antiretroviral regimen simplification improves quality of life and medication adherence while reducing the risk of HIV virologic failure (VF) and long-term drug-related toxicities. Emtricitabine/rilpivirine/tenofovir disoproxil fumarate (FTC/RPV/TDF)